We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BioLegend Takes a Look at ASC Specks
Product News

BioLegend Takes a Look at ASC Specks

BioLegend Takes a Look at ASC Specks
Product News

BioLegend Takes a Look at ASC Specks


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "BioLegend Takes a Look at ASC Specks"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Amyloid beta deposits can often trigger an innate immune response from microglia. This inflammatory process leads to IL-1β activation and the formation of inflammasomes. Following inflammasome formation, ASC specks can be created and released from the cell. Venegas et al. investigated the ability of ASC specks to promote amyloid beta aggregation and spreading, linking inflammasome activity with Alzheimer's disease progression.

BioLegend provides direct conjugates and purified versions of trusted clones to examine microglia, inflammasomes, and amyloid beta in the advancement of Alzheimer's disease research.
Advertisement